TECHNETIUM TC-99M PENTETATE KIT

Post-LOE

kit for the preparation of technetium tc 99m pentetate

Curium Pharma

ANDAINJECTIONINJECTABLE

Approved

Mar 2025

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

TECHNETIUM TC-99M PENTETATE KIT (kit for the preparation of technetium tc 99m pentetate) by Curium Pharma is lead chelating activity [moa]. Approved for pulmonary embolism. First approved in 2025.

Drug data last refreshed Yesterday

Mechanism of Action

Lead Chelating Activity

Pharmacologic Class:

Lead Chelator

Indications (1)

pulmonary embolism

Company

Worked on TECHNETIUM TC-99M PENTETATE KIT at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.